Skip to content

Trial for reduction of anxiety and fatigue -open study-

Trial for reduction of anxiety and fatigue -open study- - Trial for reduction of anxiety and fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042928
Enrollment
20
Registered
2022-01-13
Start date
2021-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 2 tablets of test food with water twice a day

Sponsors

IMEQRD inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 20 to under 65 at the time of informed consent. 2. Japanese females. 3. Those who are menopausal. 4. Those who do not need treatment but have anxiety of fatigue. 5. Those who feel more anxious than last year. 6. Those who can input electronic diary with smartphone / PC. 7. Those who understand the contents of the study and obtain written consent before the test based on the person's free will.

Exclusion criteria

Exclusion criteria: Subjects who 1. are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed). 2. plan to change their lifestyle during the test. 3. have a serious illness such as liver, kidney, heart, respiratory tract, endocrine, metabolic disease, etc.. 4. are receiving treatment for mental illness such as depression or anxiety disorder, or have a history of it. 5. May take sleeping pills/ sleep-inducing drugs during the test period, continuously or when they need. 6. Have been diagnosed with chronic fatigue syndrome. 7. Have had life events that affect their mind and body such as loss of important things within one month (death of relatives, loss of employment, divorce, pet death). 8. Take healthy foods or supplements daily. (acceptable if they can stop taking after obtaining consent.) 9. have a past and current medical history of drug or food allergy. 10. have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period. 11. consume alcohol excessively (alcohol equivalent 60g or more / day). 12. have smoking habit. 13. have an irregular diet, or irregular life rhythms (work in shifts, work late at night etc.). 14. are judged by the investigator to be unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
fatigue VAS score(anxiety fatigue) QOL questionnaire (behavior changes) Sleep questionnaire (SMH)

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026